Lobbying client · LD-2 disclosures
Old North Strategies, LLC on Behalf of Exela Pharma Sciences, LLC
North Carolina
25 filings from 2 registrants · 2023–2026 · latest filed Jul 14, 2026
Reported on its behalf
$665K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$665K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
14 filings
$609K on those filings
Manufacturing
MAN
14 filings
$609K on those filings
Government Issues
GOV
Who did the lobbying
Every lobbyist named on this client's filings.
- Joseph Robert Murray First Principles Strategies, LLCCovered position: Senator Ron Johnson, Republican Study Committee, Rep. Mark Meadows14 filingsthrough 2026
- Glenn Rushing Peter Damon Group LLC3 filingsthrough 2025
- Darren Peters Peter Damon Group LLC2 filingsthrough 2023
Covered positions · 1 of 3 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 25 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: old-north-strategies-llc-on-behalf-of-exela-pharma-sciences-llc.